Sökning: onr:"swepub:oai:DiVA.org:liu-152632" > Cardiac Troponin T ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04919naa a2200469 4500 | |
001 | oai:DiVA.org:liu-152632 | |
003 | SwePub | |
008 | 181109s2018 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1526322 URI |
024 | 7 | a https://doi.org/10.1373/clinchem.2018.2888942 DOI |
040 | a (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Myhre, Peder L.u Akershus Univ Hosp, Norway; Univ Oslo, Norway; Brigham and Womens Hosp, MA 02115 USA; Harvard Med Sch, MA USA4 aut |
245 | 1 0 | a Cardiac Troponin T Concentrations, Reversible Myocardial Ischemia, and Indices of Left Ventricular Remodeling in Patients with Suspected Stable Angina Pectoris: a DOPPLER-CIP Substudy |
264 | c 2018-09-01 | |
264 | 1 | b AMER ASSOC CLINICAL CHEMISTRY,c 2018 |
338 | a print2 rdacarrier | |
500 | a Funding Agencies|Akershus University Hospital; Norwegian Research Council; South-Eastern Regional Health Authority; EU (FP7) framework program; South-Eastern Norway Regional Health Authority; Roche Diagnostics | |
520 | a BACKGROUND: Cardiac troponin T concentrations measured with high-sensitivity assays (hs-cTnT) provide important prognostic information for patients with stable coronary artery disease (CAD). However, whether hsc-TnT concentrations mainly reflect left ventricular (LV) remodeling or recurrent myocardial ischemia in this population is not known. METHODS: We measured hs-cTnT concentrations in 619 subjects with suspected stable CAD in a prospectively designed multicenter study. We identified associations with indices of LV remodeling, as assessed by cardiac MRI and echocardiography, and evidence of myocardial ischemia diagnosed by single positron emission computed tomography. RESULTS: Median hs-cTnT concentration was 7.8 ng/L (interquartile range, 4.8 -11.6 ng/L), and 111 patients (18%) had hs-cTnT concentrations above the upper reference limit (amp;gt; 14 ng/L). Patients with hs-cTnT amp;gt; 14 ng/L had increased LV mass (144 +/- 40 g vs 116 +/- 34 g; P amp;lt; 0.001) and volume (179 +/- 80 mL vs 158 +/- 44 mL; P = 0.006), lower LV ejection fraction (LVEF) (59 +/- 14 vs 62 +/- 11; P = 0.006) and global longitudinal strain (14.1 +/- 3.4% vs 16.9 +/- 3.2%; P amp;lt; 0.001), and more reversible perfusion defects (P amp;lt; 0.001) and reversible wall motion abnormalities (P = 0.008). Age (P = 0.009), estimated glomerular filtration rate (P = 0.01), LV mass (P = 0.003), LVEF (P = 0.03), and evidence of reversible myocardial ischemia (P = 0.004 for perfusion defects and P = 0.02 for LV wall motion) were all associated with increasing hs-cTnT concentrations in multivariate analysis. We found analogous results when using the revised US upper reference limit of 19 ng/L. CONCLUSIONS: hs-cTnT concentrations reflect both LV mass and reversible myocardial ischemia in patients with suspected stable CAD. (c) 2018 American Association for Clinical Chemistry | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
700 | 1 | a Omland, Torbjornu Akershus Univ Hosp, Norway; Univ Oslo, Norway4 aut |
700 | 1 | a Sarvari, Sebastian I.u Univ Oslo, Norway; Univ Oslo, Norway4 aut |
700 | 1 | a Ukkonen, Heikkiu Turku Univ Hosp, Finland4 aut |
700 | 1 | a Rademakers, Franku Univ Hosp Leuven, Belgium; Katholieke Univ Leuven, Belgium4 aut |
700 | 1 | a Engvall, Janu Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Centrum för medicinsk bildvetenskap och visualisering, CMIV,Region Östergötland, Fysiologiska kliniken US4 aut0 (Swepub:liu)janen74 |
700 | 1 | a Hagve, Tor-Arneu Akershus Univ Hosp, Norway; Univ Oslo, Norway4 aut |
700 | 1 | a Nagel, Eikeu Kings Coll Hosp London, England4 aut |
700 | 1 | a Sicari, Rosau CNR, Italy4 aut |
700 | 1 | a Zamorano, Jose L.u Hosp Univ Ramon and Cajal, Spain4 aut |
700 | 1 | a Monaghan, Marku Kings Coll Hosp London, England4 aut |
700 | 1 | a Dhooge, Janu Univ Hosp Leuven, Belgium; Katholieke Univ Leuven, Belgium4 aut |
700 | 1 | a Edvardsen, Thoru Univ Oslo, Norway4 aut |
700 | 1 | a Rosjo, Helgeu Akershus Univ Hosp, Norway; Univ Oslo, Norway4 aut |
710 | 2 | a Akershus Univ Hosp, Norway; Univ Oslo, Norway; Brigham and Womens Hosp, MA 02115 USA; Harvard Med Sch, MA USAb Akershus Univ Hosp, Norway; Univ Oslo, Norway4 org |
773 | 0 | t Clinical Chemistryd : AMER ASSOC CLINICAL CHEMISTRYg 64:9, s. 1370-1379q 64:9<1370-1379x 0009-9147x 1530-8561 |
856 | 4 | u https://academic.oup.com/clinchem/article-pdf/64/9/1370/32642963/clinchem1370.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-152632 |
856 | 4 8 | u https://doi.org/10.1373/clinchem.2018.288894 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy